Mission:

Cambium Oncology develops first-in-class immunotherapies that improve outcomes for cancer patients.

Vision:

Our vision is to become a global leader in immune checkpoint innovation, delivering safer, more effective, and accessible cancer treatments while creating lasting value for patients and investors.

Core
Values



  • Focus: Our decisions are guided by the responsibility to deliver novel, safe, effective, and life-saving therapies for patients.
  • Innovation: We pursue bold science and disciplined development that translates into measurable clinical and business impact.
  • Transparency: Open communication, data integrity, and responsible stewardship guide our relationships with employees, partners, suppliers and investors.
  • Engagement: We ensure equitable access to opportunities for patients, staff, and shareholders, and welcome diverse perspectives in guiding our science and business strategy.
  • Collaboration: We thrive through partnerships that accelerate discovery, development, and long-term success.